Caveolin-3 Rabbit pAb
Cat No.: APA1943

Product Name: | Caveolin-3 Rabbit pAb |
Cat No.: | APA1943 |
source: | Rabbit |
reactivity: | Human, Mouse, Rat |
applications: | WB,IP |
clonality: | Polyclonal |
recommended dilution: | WB: 1:1000 IP: 1:20 |
format: | Liquid |
isotype: | IgG |
immunogen: | A synthetic peptide of human Caveolin-3 |
calculated molecular weight: | 17 kDa |
observed molecular weight: | 17 kDa |
genbank accession number: | P56539 |
gene id (ncbi): | 859 |
purification method: | Affinity Purification |
conjugate: | Un-conjugated |
storage: | Store at -20°C. Supplied in 50nM Tris-Glycine(pH 7.4), 0.15M NaCl, 40%Glycerol, 0.01% sodium azide and 0.05% BSA. Stable for 12 months from date of receipt. |
synonyms: | LQT9; MPDT; RMD2; VIP21; LGMD1C; VIP-21 |
category: | Primary Ab |
concentration: | 0.5mg/ml |
background: | This gene encodes a caveolin family member, which functions as a component of the caveolae plasma membranes found in most cell types. Caveolin proteins are proposed to be scaffolding proteins for organizing and concentrating certain caveolin-interacting molecules. Mutations identified in this gene lead to interference with protein oligomerization or intra-cellular routing, disrupting caveolae formation and resulting in Limb-Girdle muscular dystrophy type-1C (LGMD-1C), hyperCKemia or rippling muscle disease (RMD). Alternative splicing has been identified for this locus, with inclusion or exclusion of a differentially spliced intron. In addition, transcripts utilize multiple polyA sites and contain two potential translation initiation sites. [provided by RefSeq, Jul 2008] |